» Articles » PMID: 32259026

Systems Genetics Applications in Metabolism Research

Overview
Journal Nat Metab
Publisher Springer Nature
Specialty Endocrinology
Date 2020 Apr 8
PMID 32259026
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The common forms of metabolic diseases are highly complex, involving hundreds of genes, environmental and lifestyle factors, age-related changes, sex differences and gut-microbiome interactions. Systems genetics is a population-based approach to address this complexity. In contrast to commonly used 'reductionist' approaches, such as gain or loss of function, that examine one element at a time, systems genetics uses high-throughput 'omics' technologies to quantitatively assess the many molecular differences among individuals in a population and then to relate these to physiologic functions or disease states. Unlike genome-wide association studies, systems genetics seeks to go beyond the identification of disease-causing genes to understand higher-order interactions at the molecular level. The purpose of this review is to introduce the systems genetics applications in the areas of metabolic and cardiovascular disease. Here, we explain how large clinical and omics-level data and databases from both human and animal populations are available to help researchers place genes in the context of pathways and networks and formulate hypotheses that can then be experimentally examined. We provide lists of such databases and examples of the integration of reductionist and systems genetics data. Among the important applications emerging is the development of improved nutritional and pharmacological strategies to address the rise of metabolic diseases.

Citing Articles

Establishing the hybrid rat diversity program: a resource for dissecting complex traits.

Dwinell M, Takizawa A, Tutaj M, Malloy L, Schilling R, Endsley A Mamm Genome. 2025; 36(1):25-37.

PMID: 39907792 PMC: 11880076. DOI: 10.1007/s00335-024-10102-y.


Combinatorial In Vivo Genome Editing Identifies Widespread Epistasis and an Accessible Fitness Landscape During Lung Tumorigenesis.

Hebert J, Tang Y, Szamecz M, Andrejka L, Lopez S, Petrov D Mol Biol Evol. 2025; 42(2).

PMID: 39907430 PMC: 11824425. DOI: 10.1093/molbev/msaf023.


Scrutinizing neurodegenerative diseases: decoding the complex genetic architectures through a multi-omics lens.

Cocos R, Popescu B Hum Genomics. 2024; 18(1):141.

PMID: 39736681 PMC: 11687004. DOI: 10.1186/s40246-024-00704-7.


Unlocking metabolic insights with mouse genetic diversity.

Masson S, Cutler H, James D EMBO J. 2024; 43(21):4814-4821.

PMID: 39284908 PMC: 11535531. DOI: 10.1038/s44318-024-00221-2.


Striving for clarity in language about gene expression.

Cunningham A, Gorospe M Nucleic Acids Res. 2024; 52(18):10747-10753.

PMID: 39271127 PMC: 11472038. DOI: 10.1093/nar/gkae764.


References
1.
Civelek M, Lusis A . Systems genetics approaches to understand complex traits. Nat Rev Genet. 2013; 15(1):34-48. PMC: 3934510. DOI: 10.1038/nrg3575. View

2.
Hasin Y, Seldin M, Lusis A . Multi-omics approaches to disease. Genome Biol. 2017; 18(1):83. PMC: 5418815. DOI: 10.1186/s13059-017-1215-1. View

3.
Karczewski K, Snyder M . Integrative omics for health and disease. Nat Rev Genet. 2018; 19(5):299-310. PMC: 5990367. DOI: 10.1038/nrg.2018.4. View

4.
Li H, Wang X, Rukina D, Huang Q, Lin T, Sorrentino V . An Integrated Systems Genetics and Omics Toolkit to Probe Gene Function. Cell Syst. 2017; 6(1):90-102.e4. DOI: 10.1016/j.cels.2017.10.016. View

5.
Riordan J, Nadeau J . From Peas to Disease: Modifier Genes, Network Resilience, and the Genetics of Health. Am J Hum Genet. 2017; 101(2):177-191. PMC: 5544383. DOI: 10.1016/j.ajhg.2017.06.004. View